0NJP Stock Chart & Stats
€58.00
€1.36(3.68%)
At close: 4:00 PM EST
€58.00
€1.36(3.68%)
Day’s Range― - ―
52-Week Range€45.15 - €63.50
Previous CloseN/A
Volume34.95K
Average Volume (3M)2.31K
Market Cap
€5.42B
Enterprise Value€5.88B
Total Cash (Recent Filing)€312.81M
Total Debt (Recent Filing)€878.27M
Price to Earnings (P/E)31.3
Beta0.51
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.91
Shares Outstanding90,700,000
10 Day Avg. Volume1,810
30 Day Avg. Volume2,306
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)3.91
Price to Sales (P/S)2.50
P/FCF Ratio178.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.12
Revenue Forecast (FY)€1.98B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthA multi-year record of positive revenue growth indicates sustained demand and expanding business activity rather than reliance on a single period. Continued top-line progress can support operating leverage, reinvestment, and stronger competitive positioning over the next several quarters.
Stable Operating ProfitabilityStable mid-teens EBIT margins and strong EBITDA margins demonstrate durable operating profitability despite revenue growth fluctuations. This provides financial resilience, supports internal funding of operations, and suggests the company has maintained a solid earnings base across recent years.
Healthy Returns And Reasonable LeverageConsistently healthy returns on equity indicate that the company has generated meaningful profitability from its capital base. Historically moderate leverage provides a foundation for financial flexibility, allowing the business to fund operations and pursue growth without relying excessively on debt.
Bears Say
Declining Free Cash FlowDeclining free cash flow weakens the quality of reported earnings and reduces funds available for debt reduction, investment, dividends, or other capital allocation. Because cash conversion was especially limited in 2025, financial flexibility may remain constrained even while the business stays profitable.
Higher 2025 LeverageThe recent increase in total debt and debt-to-equity reduces balance-sheet flexibility relative to the company’s prior position. Higher leverage can make the business more sensitive to weaker earnings or financing costs, while limiting room to absorb operational pressure or fund initiatives internally.
Gross Margin VolatilityLarge changes in gross margin introduce uncertainty into the durability of earnings because they may reflect shifting costs, pricing, or product mix. Even with stable EBIT margins, recurring gross-profit volatility can complicate forecasting and increase the risk of future profitability pressure.
SOL SPA News
0NJP FAQ
What was SOL SPA’s price range in the past 12 months?
SOL SPA lowest share price was €45.15 and its highest was €63.50 in the past 12 months.
What is SOL SPA’s market cap?
SOL SPA’s market cap is €5.42B.
When is SOL SPA’s upcoming earnings report date?
SOL SPA’s upcoming earnings report date is Apr 01, 2027 which is in 156 days.
How were SOL SPA’s earnings last quarter?
SOL SPA released its earnings results on Sep 03, 2026. The company reported €0.991 earnings per share for the quarter.
Is SOL SPA overvalued?
According to Wall Street analysts SOL SPA’s price is currently Overvalued.
Does SOL SPA pay dividends?
SOL SPA does not currently pay dividends.
What is SOL SPA’s EPS estimate?
SOL SPA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SOL SPA have?
SOL SPA has 90,700,000 shares outstanding.
What happened to SOL SPA’s price movement after its last earnings report?
SOL SPA reported an EPS of €0.991 in its last earnings report. Following the earnings report the stock price went up 1.601%.
Which hedge fund is a major shareholder of SOL SPA?
Currently, no hedge funds are holding shares in GB:0NJP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SOL SPA
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.